Literature DB >> 20016063

Modulation of Wnt signaling by the nuclear localization of cellular FLIP-L.

Ryohei Katayama1, Toshiyasu Ishioka, Shinji Takada, Ritsuko Takada, Naoya Fujita, Takashi Tsuruo, Mikihiko Naito.   

Abstract

Cellular FLIP (cFLIP) inhibits the apoptosis signaling initiated by death receptor ligation. We previously reported that a long form of cFLIP (cFLIP-L) enhances Wnt signaling via inhibition of beta-catenin ubiquitylation. In this report, we present evidence that cFLIP-L translocates into the nucleus, which could have a role in modulation of Wnt signaling. cFLIP-L has a functional bipartite nuclear localization signal (NLS) at the C-terminus. Wild-type cFLIP-L (wt-FLIP-L) localizes in both the nucleus and cytoplasm, whereas NLS-mutated cFLIP-L localizes predominantly in the cytoplasm. cFLIP-L also has a nuclear export signal (NES) near the NLS, and leptomycin B, an inhibitor of CRM1-dependent nuclear export, increases the nuclear accumulation of cFLIP-L, suggesting that it shuttles between the nucleus and cytoplasm. Expression of mutant cFLIP-L proteins with a deletion or mutations in the NLS and NES confers resistance to Fas-mediated apoptosis, as does wt-FLIP-L, but they do not enhance Wnt signaling, which suggests an important role of the C-terminus of cFLIP-L in Wnt-signaling modulation. When wt-FLIP-L is expressed in the cytoplasm by conjugation with exogenous NES (NES-FLIP-L), Wnt signaling is not enhanced, whereas the NES-FLIP-L increases cytoplasmic beta-catenin as efficiently as wt-FLIP-L. cFLIP-L physically interacts with the reporter plasmid for Wnt signaling, but not with the control plasmid. These results suggest a role for nuclear cFLIP-L in the modulation of Wnt signaling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20016063     DOI: 10.1242/jcs.058602

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  17 in total

1.  Nuclear translocation of anamorsin during drug-induced dopaminergic neurodegeneration in culture and in rat brain.

Authors:  Kyung-Ah Park; Nuri Yun; Dong-Ik Shin; So Yoen Choi; Hyun Kim; Won-Ki Kim; Yuzuru Kanakura; Hirohiko Shibayama; Young J Oh
Journal:  J Neural Transm (Vienna)       Date:  2010-10-06       Impact factor: 3.575

2.  4-(4-Chloro-2-methylphenoxy)-N-hydroxybutanamide (CMH) targets mRNA of the c-FLIP variants and induces apoptosis in MCF-7 human breast cancer cells.

Authors:  Khadijeh Bijangi-Vishehsaraei; Mohammad Reza Saadatzadeh; Su Huang; Ahmad R Safa; Michael P Murphy
Journal:  Mol Cell Biochem       Date:  2010-05-06       Impact factor: 3.396

3.  Type I interferons induce apoptosis by balancing cFLIP and caspase-8 independent of death ligands.

Authors:  Amir Apelbaum; Ganit Yarden; Shira Warszawski; Daniel Harari; Gideon Schreiber
Journal:  Mol Cell Biol       Date:  2012-12-10       Impact factor: 4.272

4.  C-FLIPL Modulated Wnt/β-Catenin Activation via Association with TIP49 Protein.

Authors:  Jing Zhang; Heng-Yi Jiang; Lin-Kai Zhang; Wen-Ling Xu; Yi-Ting Qiao; Xu-Guo Zhu; Wan Liu; Qian-Qian Zheng; Zi-Chun Hua
Journal:  J Biol Chem       Date:  2016-12-27       Impact factor: 5.157

5.  An actin-regulated importin α/β-dependent extended bipartite NLS directs nuclear import of MRTF-A.

Authors:  Rafał Pawłowski; Eeva Kaisa Rajakylä; Maria K Vartiainen; Richard Treisman
Journal:  EMBO J       Date:  2010-09-03       Impact factor: 11.598

6.  Differential modulation of TCF/LEF-1 activity by the soluble LRP6-ICD.

Authors:  Brandon Beagle; Gail V W Johnson
Journal:  PLoS One       Date:  2010-07-28       Impact factor: 3.240

Review 7.  c-FLIP, a master anti-apoptotic regulator.

Authors:  A R Safa
Journal:  Exp Oncol       Date:  2012-10

8.  cFLIPL Interrupts IRF3-CBP-DNA Interactions To Inhibit IRF3-Driven Transcription.

Authors:  Lauren T Gates; Joanna L Shisler
Journal:  J Immunol       Date:  2016-06-24       Impact factor: 5.422

9.  Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy.

Authors:  Ahmad R Safa; Karen E Pollok
Journal:  Cancers (Basel)       Date:  2011-06       Impact factor: 6.639

10.  The endogenous caspase-8 inhibitor c-FLIPL regulates ER morphology and crosstalk with mitochondria.

Authors:  E S Marini; C Giampietri; S Petrungaro; S Conti; A Filippini; L Scorrano; E Ziparo
Journal:  Cell Death Differ       Date:  2014-12-12       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.